Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1194090

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1194090

Competent Cells

PUBLISHED:
PAGES: 196 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 14850

Add to Cart

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Competent Cells Market to Reach $3.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Competent Cells estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$3.2 Billion by 2030, growing at aCAGR of 8% over the period 2022-2030. Chemically Competent Cells, one of the segments analyzed in the report, is projected to record 7.3% CAGR and reach US$2.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Electrocompetent Cells segment is readjusted to a revised 9.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $502.7 Million, While China is Forecast to Grow at 7.5% CAGR

The Competent Cells market in the U.S. is estimated at US$502.7 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$553.3 Million by the year 2030 trailing a CAGR of 7.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Select Competitors (Total 46 Featured):

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • GenScript Biotech Corporation
  • Illumina, Inc.
  • Merck KgaA
  • New England Biolabs, Inc.
  • OriGene Technologies, Inc.
  • Promega Corporation
  • Qiagen NV
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.
  • Zymo Research Corporation
Product Code: MCP11217

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Competent Cells - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competent Cells Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
    • Clean-Label Starch Innovations
    • Chemically Competent Cells Segment Dominate in North America
    • Drivers & Restrains Summarized for Competent Cells Market
    • Cloning is Expected to Take the Largest Share of Competent Cells Market
    • Competent Cells Growth Outlook
    • Competent Cells Application Trends
    • Academic and Research Institutes Emerge as Largest End Users of Competent Cells Market
    • Leading Players in competent cells market
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Molecular Cloning Drives Competent Cell Market
    • Drivers and Restraints Summarised
    • SGI-DNA Inc has Launched Vmax™ Express Chemically Competent Cells .
    • Increasing Research on Cloning Demands Competent Cells Requirement
    • Increasing Intensity of Research and Technological Advancements Drives Market
    • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
    • As the Foundation for Modern Biomolecular Research, Importance of Recombinant Proteins Spurs Demand for Competent Cells
    • Expanding Use of Protein Expression in the Production of Therapeutic Proteins Ranging from Insulin, Interferons & Interleukins to Drive Demand for Competent Cells: Global Market for Protein Expression (In US$ Million) for the Years 2017, 2019 & 2022
    • As Molecular Engineering Takes Huge Strides Forward in Manipulating & Harnessing the DNA for the Production of More Potent Therapies, Poised to Benefit are Ready-to-Use Competent Cells
    • Escherichia coli, the Most Widely Used Organism in the Expression of Cloned Proteins
    • Need for DNA Library Construction in Molecular Cloning Benefits Demand for Competent Cells
    • Need for Faster Characterization Proteins & More Efficient Protein Expression Spurs the Use of Competent Cells
    • Rise of Protein Expression Services Offering Flexible, Low-Cost Production of High-Quality, Bioactive Recombinant Proteins, Bodes Well for Market Growth
    • Higher Transformation Efficiencies Give Electroporation an Edge Over Chemical Methods
    • Heat Shock Treatment for Transformation of Competent Cells, Another Popular Method
    • Increased Investments in Life Sciences Research to Expand the Addressable Market Opportunity for Competent Cells
    • Rising Global Pharmaceutical R&D Offers a Fertile Environment for the Growth in Demand for Competent Cells: Global Pharmaceutical R&D (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
    • Continuous Developments in Chemical Transformation Technologies to Benefit Market Growth
    • Rise in Non-Communicable Diseases, a Key Macro Trend Shaping Demand for Recombinant Enzymes & Proteins in Drug Discovery
    • Mind Bending Economic Burden of Noncommunicable Diseases (NCDs) Drives Urgent Investments in Drug Research & Development, Opening Up Opportunities for Competent Cells in Mass Production of Therapeutic Proteins: Cumulative Global Burden of NCDs (In US$ Trillion) for the Period 2011-2030
    • Cell Free Protein Expression & the Accompanying Promise of the Development of a Versatile Mass Production System for Protein Expression to Benefit Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Competent Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Competent Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Chemically Competent Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Chemically Competent Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Electrocompetent Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Electrocompetent Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cloning by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Cloning by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Protein Expression by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Protein Expression by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 15: World Competent Cells Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 17: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 19: World 8-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • JAPAN
    • Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Japan 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • CHINA
    • Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 41: China 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 43: China 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • EUROPE
    • Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Competent Cells by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe 8-Year Perspective for Competent Cells by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • FRANCE
    • Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 53: France 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 55: France 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • GERMANY
    • Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Germany 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Germany 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Italy 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Italy 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • UNITED KINGDOM
    • Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 71: UK 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 73: UK 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Competent Cells Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Competent Cells by Type - Chemically Competent Cells and Electrocompetent Cells - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Rest of World 8-Year Perspective for Competent Cells by Type - Percentage Breakdown of Value Sales for Chemically Competent Cells and Electrocompetent Cells for the Years 2023 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Competent Cells by Application - Cloning, Protein Expression and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Rest of World 8-Year Perspective for Competent Cells by Application - Percentage Breakdown of Value Sales for Cloning, Protein Expression and Other Applications for the Years 2023 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Competent Cells by End-Use - Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World 8-Year Perspective for Competent Cells by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes, Pharma & Biotech Companies and Contract Research Organizations for the Years 2023 & 2030

IV. COMPETITION

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!